Esperion Therapeutics
ESPR
ESPR
44 hedge funds and large institutions have $46.7M invested in Esperion Therapeutics in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.9M | |
| 2 | +$2.6M | |
| 3 | +$2.35M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$859K |
| 5 |
Millennium Management
New York
|
+$824K |
Top Sellers
| 1 | -$5.55M | |
| 2 | -$2.05M | |
| 3 | -$1.57M | |
| 4 |
O
OrbiMed
New York
|
-$1.15M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$979K |